Venture Capital Turns to Mundane Industries AI and Dealmaking in Accounting and Property Management SafeHaven Currencies Yen and Franc Rally Amid DeepSeek AI Sector Disruption Pokmon Card Market Surges Amid Nostalgia Speculation and HighProfile Collectors Nvidia Earnings in Focus Jensen Huangs Commentary on Trump and China Chip Restrictions After Xi Summit April Jobs Report Expected to Show Cooling Yet Resilient Labor Market Yaashvi Jewellers IPO Sees 118x Subscription on Day 3 Price Band Set at 83 FRPT Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges ARVN Q1 2026 Earnings NarrowerThanExpected Loss Provides Positive Signal Amid Pipeline Progress WFC Q1 2026 Earnings Narrow EPS Beat Lifts Shares as Revenue Picture Remains Unclear RCON Q4 2025 Earnings EPS Surprise Beats Estimates Amid Revenue Uncertainty UXIN Q1 2025 Earnings Narrowing Loss Reported Stock Edges Lower ORI Q1 2026 Earnings EPS Misses Estimates by 15 Stock Declines Slightly Enanta Pharmaceuticals ENTA Dips 3 as Support at 1285 Comes into Focus San Juan Basin Royalty Trust SJT Edges Higher Amid Modest Uptick Global Interactive Technologies GITS Faces Sharp Pullback Tests Key Support at 152 Wah Fu Education Group WAFU Holds Steady at 165 Amid Narrow Trading Range Rezolute Inc RZLT Pushes Higher on Modest Volume as Traders Eye Biotech Catalysts Fed Minutes Reveal Majority of Officials Anticipate Rate Hikes If Inflation Persists Amid Geopolitical Tensions RLJ Lodging Trust Q1 2026 Earnings Narrower Loss Beats Estimates as Cost Discipline Supports Results YD Bio Warrants Dip 6 as Support Level Approaches MTNB Q4 2024 Earnings Narrowed Loss Surpasses Expectations Pipeline Momentum Continues TBCH Q1 2026 Earnings EPS Misses Estimates Sharply Yet Stock Surges Over 11 Buckle Inc BKE Q1 2026 Earnings Earnings Beat Estimates Despite Flat Revenue Trends Chemung Financial Corp CHMG Q1 2026 Earnings Strong Earnings Beat Amid Stable Banking Operations WHD Q1 2026 Earnings EPS Beats Estimates by 861 Stock Edges Higher JPM Q1 2026 Earnings EPS Beats Estimates by Nearly 8 as Strong Trading and Investment Banking Results Drive Performance PRME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline